Venture Certified
| 기술평가보증기업(기금) | 2018-03-26 ~ 2020-03-25 | 20180103102 | 2018-03-26 |
| 기술평가보증기업(기금) | 2020-03-26 ~ 2022-03-25 | 20200102800 | 2018-03-26 |
| 연구개발유형 | 2022-03-26 ~ 2025-03-25 | 20220324020037 | 2018-03-26 |
| 혁신성장유형 | 2025-03-26 ~ 2028-03-25 | 20250416030064 | 2018-03-26 |
Revenue CAGR -32.5%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 1.3B | 2.1B | 2.9B |
| Operating Profit | -17.9B | -28.0B | -22.7B |
| Net Profit | -18.0B | -27.2B | -22.5B |
| Total Assets | 21.9B | 21.2B | 49.4B |
| Total Liabilities | 10.1B | 11.3B | 12.3B |
| Total Equity | 11.9B | 9.9B | 37.1B |
Operating Loss: Op. profit -18B
Revenue down 39% YoY
3 Consecutive Years of Net Loss
▼ 47.9%
▲ 29.4%
▼ 30.8%
▲ 15.7%
▲ 9.4%
| Name | Position | Role |
|---|---|---|
| 이성운 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전 유성구",
"ceo_name": "이성운",
"certificate": [
{
"cert_number": "20180103102",
"changes": "",
"disclosure_date": "2018-03-26",
"first_cert_date": "2018-03-26",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-03-26 ~ 2020-03-25"
},
{
"cert_number": "20200102800",
"changes": "",
"disclosure_date": "2020-03-12",
"first_cert_date": "2018-03-26",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-03-26 ~ 2022-03-25"
},
{
"cert_number": "20220324020037",
"changes": "",
"disclosure_date": "2022-03-24",
"first_cert_date": "2018-03-26",
"no": "3",
"type": "연구개발유형",
"valid_period": "2022-03-26 ~ 2025-03-25"
},
{
"cert_number": "20250416030064",
"changes": "",
"disclosure_date": "2025-04-16",
"first_cert_date": "2018-03-26",
"no": "4",
"type": "혁신성장유형",
"valid_period": "2025-03-26 ~ 2028-03-25"
}
],
"company_name": "(주) 레보스케치",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 240460000,
"cost_of_sales": 56349000,
"current_assets": 4683823000,
"current_liabilities": 736422000,
"gross_profit": 229016000,
"net_income": -2252623000,
"net_income_bs": -2252623000,
"non_current_assets": 256676000,
"non_current_liabilities": 490892000,
"non_operating_expenses": 21350000,
"non_operating_income": 36103000,
"operating_profit": -2267376000,
"revenue": 285365000,
"sga_expenses": 2496392000,
"total_assets": 4940499000,
"total_equity": 3713185000,
"total_liabilities": 1227314000
},
"2023": {
"capital_stock": 240460000,
"cost_of_sales": 137734000,
"current_assets": 1758716000,
"current_liabilities": 763306000,
"gross_profit": 75621000,
"net_income": -2722702000,
"net_income_bs": -2722702000,
"non_current_assets": 359495000,
"non_current_liabilities": 364422000,
"non_operating_expenses": 28818000,
"non_operating_income": 103501000,
"operating_profit": -2797385000,
"revenue": 213355000,
"sga_expenses": 2873006000,
"total_assets": 2118211000,
"total_equity": 990483000,
"total_liabilities": 1127728000
},
"2024": {
"capital_stock": 252160000,
"cost_of_sales": 43479000,
"current_assets": 1946602000,
"current_liabilities": 255736000,
"gross_profit": 86353000,
"net_income": -1803734000,
"net_income_bs": -1803734000,
"non_current_assets": 248300000,
"non_current_liabilities": 752653000,
"non_operating_expenses": 32216000,
"non_operating_income": 16483000,
"operating_profit": -1788001000,
"revenue": 129832000,
"sga_expenses": 1874354000,
"total_assets": 2194902000,
"total_equity": 1186513000,
"total_liabilities": 1008389000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [],
"main_products": "PCR , 진단키트, 분자진단기기 외",
"phone": "042-710-****",
"years": [
2024,
2023,
2022
]
}